Sample 4 Treatment Agreement
Provides a sample consent for treatment with buprenorphine/naloxone.
A collection of tools and resources for providers, staff, and patients who offer or use services to address substance use. See the full environmental scan (PDF 0.69 MB) and resources collection (PDF 1.28 MB) in PDF format.
Provides a sample consent for treatment with buprenorphine/naloxone.
Presents a sample intake questionnaire for patient treatment-planning questions.
This web page outlines policies on substance use during pregnancy, categorizing how these policies differ from state to state.
Maternal Mortality Review Committees (MMRCs) are multi-disciplinary committees that convene at the state or local level to comprehensively review deaths of women during or within a year of pregnancy. This document summarizes substance use disorder findings in a recent review of MMRC data in 14 states.
This is the first in a series of articles on state policies that support or inhibit postpartum women’s (PPWs’) access to long-term recovery from opioid-use disorders (OUDs). It reviews current federal and state policies on mandatory reporting by health care professionals of a patient's substance use during pregnancy and their implications
SAMHSA offers evidence-based resources to help providers screen, diagnose, and deliver integrated care to patients with co-occurring disorders.
Provides principles and recommendations for the treatment of pain syndromes with buprenorphine and buprenorphine/naloxone for clinicians.